Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Atcor Medical Holdings Ltd's SphygmoCor XCEL approved for sale in China


Monday, 13 Jan 2014 05:45pm EST 

Atcor Medical Holdings Ltd:Says that its SphygmoCor XCEL system has been approved by the China Food and Drug Administration (CFDA).Says its Chinese distributor, Angy (China) Medical Ltd, is now able to sell SphygmoCor XCEL to clinicians and researchers in mainland China. 

Company Quote

0.09
-0.0020 -2.17%
2 Oct 2014